ClinicalTrials.gg
Not yet recruitingNCT07708168Updated Jul 16, 2026

MyFILM: A Pilot Study for Social-Emotional Learning in Clinical Youth

An interventional study of MyFILM in Mood Disorders and Anxiety Disorders, sponsored by Mark Sinyor. Not yet recruiting. Open to participants aged 9 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-07-16.

Sponsored by Mark Sinyor · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Not applicable
Ages
9 Years to 12 Years
Sex
All
01

Study summary

The objective of this pilot study is to evaluate the feasibility and acceptability of MyFILM as a weekly group intervention for children aged 9-12 in a clinical setting. We will also gather preliminary data to explore changes in clinical metrics following participation in MyFILM in preparation for a full-scale clinical trial.

Primary Objective (Feasibility): To determine whether a substantial proportion of participants complete the MyFILM intervention.

Primary Objective (Acceptability): To determine whether the MyFILM intervention is acceptable to 9-12-year-old participants in a clinical setting.

Secondary Objective (Clinical Effectiveness): To determine whether participation in MyFILM show preliminary evidence of improvement in social-emotional skills, coping ability, and reduction in anxiety and depression symptoms.

Participants will:

Participate in 9 sessions of a structured group-based program.

02

Conditions studied

  • Mood Disorders
  • Anxiety Disorders
03

In context

Mood Disorders

561 studies on the registry are indexed under Mood Disorders; 105 are open to participants now.

This study's planned enrollment of 48 is below the median of 80 across 419 interventional studies indexed under Mood Disorders.

Browse Mood Disorders studies →

Lead sponsor

This is the only study on the registry with Mark Sinyor as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
9 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Be between 9 and 12 years of age at enrollment
  • Be receiving outpatient care through Sunnybrook Health Sciences Centre
  • Demonstrate elevated risk (first-degree relative with a mental illness, experiencing a major life stressor as judged by the treating physician and investigator), subclinical symptoms (symptoms of a mood and/or anxiety disorder that do not meet the threshold of a clinical diagnosis), or diagnosed mood and/or anxiety-related concerns
  • Be able to participate in group-based discussions and activities in English
  • Have parent/guardian consent and participant assent

Exclusion criteria

Exclusion Criteria:

  • Have active psychosis or mania
  • Have severe cognitive, developmental, and/or behavioural limitations preventing meaningful participation
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
48 participants (estimated)

Study arms

  • Experimental
    MyFILM

    The arm will consist of a 9-week structured and closed-group program of MyFILM intervention.

    Behavioral: MyFILM

Interventions

  • BehavioralMyFILM

    9 sessions of MyFILM: The intervention will consist of a 9-week, closed-group program delivered by a trained MSW. Sessions will occur weekly, with most sessions lasting approximately 1 hour, except for Sessions 2 and 6 (approximately 2 hours each) to accommodate in-session viewing of Inside Out films. Content comprises of psychoeducation, mental health literacy (MHL), social-emotional learning (SEL), and CBT-informed coping skills, using structured film vignettes. Sessions 1-4 introduce core concepts and skills anchored in the first film; Sessions 5-8 extend these competencies using the second film; Session 9 focuses on consolidation and skill integration.

06

What researchers measure

Primary outcomes

  1. Completion rate

    Proportion of participants who enroll in the study and complete the intervention, defined as attendance at least 70% of the scheduled sessions (i.e., ≥6 of 9 sessions).

    Time frame: At the end of the 9-week intervention

  2. Satisfaction and Acceptability Score

    The number and proportion of participants who rate the intervention positively on a post-intervention Satisfaction and Acceptability Questionnaire composed of 5-point Likert scale items.

    Time frame: At the end of the 9-week intervention

Secondary outcomes

  1. Change from baseline in SELIS score at the end of the intervention (after Session 9)

    The Social and Emotional Learning Indicator System (SELIS) Survey, which assesses core social-emotional learning competencies including self-awareness, self-management, social awareness, and relationship skills.

    Time frame: Baseline and week 9

  2. Change from baseline in KidCOPE score at the end of the intervention (after Session 9)

    The KidCOPE - Child Version, a self-report measure evaluating coping strategies used in response to stress.

    Time frame: Baseline and week 9

  3. Change from baseline in MFQ-SF score at the end of the intervention (after Session 9)

    The Mood and Feelings Questionnaire - Short Form (MFQ-SF), a widely used measure of depressive symptoms in children and adolescents.

    Time frame: Baseline and week 9

  4. Change from baseline in RCADS score at the end of the intervention (after Session 9)

    The Revised Children's Anxiety and Depression Scale (RCADS) - Generalized Anxiety and Social Phobia subscales, which assess symptoms of anxiety.

    Time frame: Baseline and week 9

  5. Change from baseline in MFQ [Parent] score at the end of the intervention (after Session 9)

    The Mood and Feelings Questionnaire - Short Form (MFQ-SF), a widely used measure of depressive symptoms in children and adolescents.

    Time frame: Baseline and week 9

  6. Change from baseline in RCADS [Parent] score at the end of the intervention (after Session 9)

    The Revised Children's Anxiety and Depression Scale (RCADS) - Generalized Anxiety and Social Phobia subscales, which assess symptoms of anxiety.

    Time frame: Baseline and week 9

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07708168
Lead sponsor
Mark Sinyor
Responsible party
Mark Sinyor (Staff Psychiatrist, Sunnybrook Health Sciences Centre) — Sponsor-investigator
First posted
Jul 16, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Mar 31, 2028 (estimated)
Completion
Mar 31, 2028 (estimated)
Last update
Jul 16, 2026

Study contacts

Rachel Lebovic, MHS
Contact
rachel.lebovic@sri.utoronto.ca
404-444-6024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion